Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Mesa Labs Inc (MLAB)

Mesa Labs Inc (MLAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 494,100
  • Shares Outstanding, K 5,394
  • Annual Sales, $ 216,190 K
  • Annual Income, $ -254,250 K
  • 60-Month Beta 0.86
  • Price/Sales 2.29
  • Price/Cash Flow 1.58
  • Price/Book 3.40
Trade MLAB with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 1.74
  • Number of Estimates 1
  • High Estimate 1.74
  • Low Estimate 1.74
  • Prior Year 1.22
  • Growth Rate Est. (year over year) +42.62%

Price Performance

See More
Period Period Low Period High Performance
1-Month
88.62 +3.44%
on 06/14/24
123.79 -25.95%
on 05/20/24
-30.55 (-25.00%)
since 05/17/24
3-Month
88.62 +3.44%
on 06/14/24
123.79 -25.95%
on 05/20/24
-9.41 (-9.31%)
since 03/15/24
52-Week
82.86 +10.63%
on 11/13/23
145.46 -36.98%
on 09/01/23
-43.88 (-32.37%)
since 06/16/23

Most Recent Stories

More News
Mesa Labs: Fiscal Q4 Earnings Snapshot

Mesa Labs: Fiscal Q4 Earnings Snapshot

MLAB : 91.67 (+0.08%)
Mesa Labs: Fiscal Q3 Earnings Snapshot

Mesa Labs: Fiscal Q3 Earnings Snapshot

MLAB : 91.67 (+0.08%)
Mesa Labs: Fiscal Q2 Earnings Snapshot

Mesa Labs: Fiscal Q2 Earnings Snapshot

MLAB : 91.67 (+0.08%)
Mesa Labs: Fiscal Q1 Earnings Snapshot

Mesa Labs: Fiscal Q1 Earnings Snapshot

MLAB : 91.67 (+0.08%)
Mesa Labs: Fiscal Q4 Earnings Snapshot

Mesa Labs: Fiscal Q4 Earnings Snapshot

MLAB : 91.67 (+0.08%)
ReWalk Robotics (RWLK) Reports Q1 Loss, Misses Revenue Estimates

ReWalk (RWLK) delivered earnings and revenue surprises of 12.50% and 38.50%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

RWLK : 1.0501 (+6.07%)
MLAB : 91.67 (+0.08%)
RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates

RxSight, Inc. (RXST) delivered earnings and revenue surprises of 19.23% and 7.20%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

RXST : 56.11 (-3.07%)
MLAB : 91.67 (+0.08%)
Shockwave Medical (SWAV) Beats Q1 Earnings and Revenue Estimates

Shockwave Medical (SWAV) delivered earnings and revenue surprises of 27.16% and 10.62%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

SWAV : 334.75 (-0.02%)
MLAB : 91.67 (+0.08%)
Paragon 28, Inc. (FNA) Reports Q1 Loss, Tops Revenue Estimates

Paragon 28, Inc. (FNA) delivered earnings and revenue surprises of -10% and 3.53%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

FNA : 6.06 (-1.46%)
MLAB : 91.67 (+0.08%)
Sensus Healthcare, Inc. (SRTS) Reports Q1 Loss, Misses Revenue Estimates

Sensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of -209.09% and 63.06%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

SRTS : 5.22 (-1.51%)
MLAB : 91.67 (+0.08%)

Business Summary

MESA LABORATORIES, INC. designs, develops, acquires, manufactures and markets instruments and systems utilized in connection with industrial applications and hemodialysis therapy.

See More

Key Turning Points

3rd Resistance Point 94.04
2nd Resistance Point 92.85
1st Resistance Point 92.26
Last Price 91.67
1st Support Level 90.49
2nd Support Level 89.30
3rd Support Level 88.71

See More

52-Week High 145.46
Fibonacci 61.8% 121.55
Fibonacci 50% 114.16
Fibonacci 38.2% 106.77
Last Price 91.67
52-Week Low 82.86

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar